Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cyclacel Pharmaceuticals, Inc. | Interim Chief Medical Officer, Director | Common Stock | 15.2K | $50.4K | $3.32 | Jan 29, 2024 | Direct |
INFINITY PHARMACEUTICALS, INC. | Director | Common Stock | 30.9K | $2.16K | $0.07 | Jun 16, 2022 | Direct |
INFINITY PHARMACEUTICALS, INC. | Director | Stock Option(right to buy) | 45K | Jun 16, 2022 | Direct | ||
Cyclacel Pharmaceuticals, Inc. | Interim Chief Medical Officer, Director | Stock Option (right to buy) | 12.5K | Jan 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CYCC | Cyclacel Pharmaceuticals, Inc. | Jan 29, 2024 | 2 | $0 | 4 | Jan 31, 2024 | Interim Chief Medical Officer, Director |
CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 30, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Jun 16, 2022 | 2 | $21K | 4 | Jun 16, 2022 | Director |
CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Sep 7, 2021 | 1 | $0 | 4 | Sep 10, 2021 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Sep 7, 2021 | 0 | $0 | 3 | Sep 10, 2021 | Director |
CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 15, 2021 | 4 | $0 | 4 | Jun 17, 2021 | Director |